Analyse BIOLASE, Inc. (BIOLQ) — Kairos Score 43/100

À propos de BIOLASE, Inc.

BIOLASE, Inc., together with its subsidiaries, develops, manufactures, markets, and sells laser systems for dental practitioners and their patients in the United States and internationally. Its dental laser systems allow dentists, periodontists, endodontists, pediatric dentists, oral surgeons, and other dental specialists to perform a range of minimally invasive dental procedures, including cosmetic, restorative, and complex surgical applications. The company provides Waterlase (all-tissue) systems for cutting soft and hard tissue; and diode (soft-tissue) systems to perform soft tissue, pain therapy, and cosmetic procedures, including teeth whitening. It also manufactures and sells consumable products and accessories for its laser systems, as well as markets flexible fibers and hand pieces; and sells teeth whitening gel kits. The company sells its products through its field sales force and distributor network. The company was formerly known as BIOLASE Technology, Inc. and changed its name to BIOLASE, Inc. in 2012. BIOLASE, Inc. was founded in 1984 and is headquartered in Foothill Ranch, California.

Informations clés

🕴️ Activité des initiés (90 jours)

0 transactions — 0 achats et 0 ventes déclarés par les dirigeants de BIOLASE, Inc..

🏦 Hedge Funds

0 fonds institutionnels déclarent une position sur BIOLQ dans leur dernière déclaration trimestrielle SEC.

📰 Actualités récentes

3 articles récents sur BIOLQ.

• MegaGen and BIOLASE Invest Nearly $1 Million to Expand Manufacturing Infrastructure at Corona, California Facility
• BIOLASE and MegaGen America Launch U.S. Commercial Collaboration to Advance "More Brilliant Dentistry Together"

🧠 Ce qui fait Kairos Insider

Au-dela des donnees brutes, nous agregeons et scoring tout le signal smart money pour vous donner une vue unique.